July 11, 2025

Delayed Breast Cancer Care Triples Death Risk

Delays longer than 90 days before seeking care for breast cancer were linked to a threefold increase in two-year mortality, particularly affecting older and socially isolated patients, according to a multicenter Spanish study.

Conexiant

July 10, 2025

Cervical Cancer Risk Remains High After 65

A new large-scale study of over 2 million women raises questions about age cutoffs in cervical cancer screening policies after findings reveal that women aged 65 and older face significantly higher rates of cervical cancer-related abnormalities and high-risk HPV infections.

Conexiant

July 03, 2025

Is HPV-Driven SNSCC Its Own Disease?

Researchers identified key genetic differences between HPV-associated and HPV-independent sinonasal squamous cell carcinoma, revealing distinct mutations, survival risks, and potential treatment targets.

Conexiant

June 16, 2025

FDA Approves Therapy for NSCLC With High c-Met Protein Overexpression

The FDA granted accelerated approval to telisotuzumab vedotin-tllv (Emrelis), a c-Met–directed antibody and microtubule inhibitor conjugate, for adults with locally advanced or metastatic, nonsquamous...

The ASCO Post

November 07, 2024

AI in Neuropathology: How Language Models Are Transforming Brain Tumor Diagnosis

New research explores how integrating AI with clinical guidelines can enhance diagnostic precision for complex brain tumors.

Conexiant

May 21, 2025

Diabetes Drug TZDs May Curb Prostate Cancer

Older type 2 diabetes drugs that target PPAR-gamma may slow prostate cancer progression.

Reuters

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

February 12, 2025

FDA & EMA: Submitted Trial Data Discrepancies

Sample size discrepancies were identified in 13 trials (65%), with 8 differing by more than 10%.

Conexiant

September 26, 2024

T Cell Spatial Patterns Linked to CRC Survival

Study links shorter T-cell proximity to cancer cells with improved survival rates in colorectal cancer.

Conexiant